Eloxx Pharmaceuticals Inc
Veridion Score
Composite trend over time
Why is ELOX moving today?
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for ELOX.
ELOX insider activity
Eloxx Pharmaceuticals Inc
No multi-insider buying cluster in the last 90 days
Net buying: $39K across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | 2026-02-28 | Aggarwal Sumit | Insider | buy | $0.15 | 260,946 | 1,672,756 | $39K | SEC Form 4 |
| 2026-05-08 | 2025-08-14 | Aggarwal Sumit | Insider | buy | $0.00 | 196,880 | 396,810 | $20 | SEC Form 4 |
ELOX contract awards, year to date.
Public federal awards linked to this ticker.
ELOX lobbying filings, year to date.
Registered lobbying filings matched to Eloxx Pharmaceuticals Inc.